Premium
Radiogenomics is the future of treatment response assessment in clinical oncology
Author(s) -
El Naqa Issam,
Napel Sandy,
Zaidi Habib
Publication year - 2018
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1002/mp.13035
Subject(s) - radiogenomics , medical physics , medicine , radiation oncology , clinical oncology , oncology , radiology , radiomics , radiation therapy , cancer
Recent literature seems to indicate strong evidence that quantitative features extracted from multimodality imaging data serve as specific biomarkers or surrogates of specific tumor molecular and genetic profiles that can predict response to treatment. As a consequence of the progress in quantitative imaging and the resurgence of systems biology and genomics, a new promising research domain, referred to as radiogenomics, has recently emerged. The approach looks promising and preliminary results reported seem to suggest relevance in clinical oncology. This article is protected by copyright. All rights reserved.